Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06094088 · ClinicalTrials.gov registry record · NA

Researching Heat and Yoga for Mood Enhancement

A NA study of Depression, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT06094088: Recruiting NA study of Depression, sponsored by Massachusetts General Hospital.

NCT06094088 is a NA study of Depression that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06094088, a NA study of Depression, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

This study will examine how doing heated yoga or non-heated yoga affects depression.

Primary Outcome

This measure is a 9-item self-report questionnaire that is widely used to assess depression symptom severity. PHQ-9 scores range from 0 to 27. A PHQ-9 score ≥10 has a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively.

Conditions Studied

Interventions

  • BEHAVIORAL Heated Yoga
  • BEHAVIORAL Non-Heated Yoga

Study Locations (2)

Massachusetts

  • Orange Door Collaborative - Cambridge
  • Breathe Yoga Studio - Cambridge

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-07-01
Est. Completion 2026-12-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06094088 shows while recruiting

NCT06094088 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Heated Yoga is the first listed.

NCT06094088 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06094088 about?

NCT06094088 is a clinical study titled "Researching Heat and Yoga for Mood Enhancement". This study will examine how doing heated yoga or non-heated yoga affects depression.

What is the current status of trial NCT06094088?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-07-01. Estimated completion is 2026-12-01.

What conditions does trial NCT06094088 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT06094088?

The interventions under investigation include: Heated Yoga (BEHAVIORAL), Non-Heated Yoga (BEHAVIORAL).

Who is sponsoring clinical trial NCT06094088?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06094088 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06094088's enrollment target sits among peer trials

120 292nd of 679 higher than 379 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06094088, the US trial registry maintained by the National Library of Medicine. NCT06094088 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.